FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Thomas Casale

Research Profile

Disorders

Chemicals & Drugs

Procedures

Living Beings

Ambrosia

Anatomy

Bronchioles

Concepts & Ideas

Treatment Outcome

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
William W Busse; Thomas B Casale; Linda Cox; Vesselin Dimov; Richard W Honsinger; Craig A Jones; Zuhair K Ballas; James M Tracy
Future of allergy/immunology task force report.
Jeffrey R Stokes; Richard J Allan; Frances Hackman; Janie Misfeldt; Peter G Phillips; Francisco A Romero; Thomas B Casale
The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
Jeffrey R Stokes; Thomas B Casale
Allergic rhinitis and asthma: celebrating 100 years of immunotherapy.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Thomas Casale (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2012: William W Busse; Thomas B Casale; Linda Cox; Vesselin Dimov; Richard W Honsinger; Craig A Jones; Zuhair K Ballas; James M Tracy
Future of allergy/immunology task force report.
The Journal of allergy and clinical immunology 2012;130(4):1009-10.
2012: Jeffrey R Stokes; Richard J Allan; Frances Hackman; Janie Misfeldt; Peter G Phillips; Francisco A Romero; Thomas B Casale
The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
The Journal of allergy and clinical immunology 2012;129(2):409-12, 412.e1-2.
2011: Jeffrey R Stokes; Thomas B Casale
Allergic rhinitis and asthma: celebrating 100 years of immunotherapy.
Current opinion in immunology 2011;23(6):808-13.
2011: Shuping Jia; Manav Segal; Zhaoyi Wang; Xintian Zhang; Abdo Berro; Trevor Gerson; David Z Z He; Thomas B Casale
Expression and function of a novel variant of estrogen receptor-α36 in murine airways.
American journal of respiratory cell and molecular biology 2011;45(5):1084-9.
2011: Thomas B Casale; Phillip E Korenblat; Eli O Meltzer; Kristen Yen; Anish Bhatnagar
Nasal carbon dioxide for the symptomatic treatment of perennial allergic rhinitis.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2011;107(4):364-70.
2011: Tran-Hoai T Nguyen; Thomas B Casale
Immune modulation for treatment of allergic disease.
Immunological reviews 2011;242(1):258-71.
2011: Tran-Hoai T Nguyen; Jeffrey R Stokes; Thomas B Casale
Future forms of immunotherapy and immunomodulators in allergic disease.
Immunology and allergy clinics of North America 2011;31(2):343-65, x-xi.
2011: Thomas B Casale; Jeffrey R Stokes
Future forms of immunotherapy.
The Journal of allergy and clinical immunology 2011;127(1):8-15; quiz 16-7.
2010: Lee E Morrow; Marin H Kollef; Thomas B Casale
Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.
American journal of respiratory and critical care medicine 2010;182(8):1058-64.
2010: Vesselin V Dimov; Thomas B Casale
Immunomodulators for asthma.
Allergy, asthma & immunology research 2010;2(4):228-34.
2010: Manbir S Sandhu; Thomas B Casale
The role of vitamin D in asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2010;105(3):191-9; quiz 200-2, 217.
2009: Vesselin V Dimov; Jeffrey R Stokes; Thomas B Casale
Immunomodulators in asthma therapy.
Current allergy and asthma reports 2009;9(6):475-83.
2009: Thomas B Casale; G Walter Canonica; Jean Bousquet; Linda Cox; Richard Lockey; Harold S Nelson; Giovanni Passalacqua
Recommendations for appropriate sublingual immunotherapy clinical trials.
The Journal of allergy and clinical immunology 2009;124(4):665-70.
2009: Priya J Warrier; Pallavi Bellamkonda; Jeffrey R Stokes; Thomas B Casale
Utility and limitations of objective measures of asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2009;102(6):518-22.
2009: Thomas B Casale; Richard J Martin
Clinical importance of identifying immunoglobulin E-mediated disease in patients with asthma.
Clinical cornerstone 2009;9(3):20-9.
2008: Daniel Waggoner; Jeffrey Stokes; Thomas B Casale
Asthma and obesity.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2008;101(6):641-3.
2008: Douglas H Jones; Francisco A Romero; Thomas B Casale
Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2008;100(5):452-6.
2008: Thomas B Casale; Jeffrey R Stokes
Immunomodulators for allergic respiratory disorders.
The Journal of allergy and clinical immunology 2008;121(2):288-96; quiz 297-8.
2008: Thomas B Casale; Francisco A Romero; Egilius L H Spierings
Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis.
The Journal of allergy and clinical immunology 2008;121(1):105-9.
2007: Sven Klunker; Lavina R Saggar; Vicki Seyfert-Margolis; Adam L Asare; Thomas B Casale; Stephen R Durham; James Francis
Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding.
The Journal of allergy and clinical immunology 2007;120(3):688-95.
2007: Harold Nelson; James Kemp; William Berger; Jonathan Corren; Thomas B Casale; Louise Dube; Karen Walton-Bowen; Nicole LaVallee; Miganush Stepanians
Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2007;99(2):178-84.
2006: Y X Cheng; Barbara Foster; S M Holland; Amy D Klion; T B Nutman; Thomas B Casale; Dean D Metcalfe; Calman Prussin
CD2 identifies a monocyte subpopulation with immunoglobulin E-dependent, high-level expression of Fc epsilon RI.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2006;36(11):1436-45.
2006: Thomas B Casale; Jean Kessler; Francisco A Romero
Safety of the intranasal toll-like receptor 4 agonist CRX-675 in allergic rhinitis.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2006;97(4):454-6.
2006: Jeffrey R Stokes; Thomas B Casale
Allergy immunotherapy for primary care physicians.
The American journal of medicine 2006;119(10):820-3.
2006: Kevin W Parks; Thomas B Casale
Anti-immunoglobulin E monoclonal antibody administered with immunotherapy.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 2006;27(2 Suppl 1):S33-6.
2006: Justin Clark; Dean Chiang; Thomas B Casale
Omalizumab in the treatment of allergic respiratory disease.
The Journal of asthma : official journal of the Association for the Care of Asthma 2006;43(2):87-93.
2006: Jeffrey Stokes; Eric Fenstad; Thomas B Casale
Managing impairment in patients with allergic rhinitis.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 2006;27(1):12-6.
2006: Jaine Brownell; Henry Lin; Againdra Bewtra; Robert G Townley; Thomas B Casale
Necrotizing pneumonia with a questionable lung mass in a 59-year-old man.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2006;96(1):116-21.
2006: William W Busse; Thomas B Casale; Mark S Dykewicz; Eli O Meltzer; Steven R Bird; Carolyn M Hustad; Evalyn Grant; Robert K Zeldin; Jonathan Edelman
Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2006;96(1):60-8.
2006: Thomas B Casale; William W Busse; Joel N Kline; Zuhair K Ballas; Mark H Moss; Robert G Townley; Masoud Mokhtarani; Vicki Seyfert-Margolis; Adam L Asare; Kirk Bateman; Yamo Deniz
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
The Journal of allergy and clinical immunology 2006;117(1):134-40.
2005: Dean T Chiang; Justin Clark; Thomas B Casale
Omalizumab in asthma: approval and postapproval experience.
Clinical reviews in allergy & immunology 2005;29(1):3-16.
2005: John B Kostis; Harold J Kim; James Rusnak; Thomas B Casale; Allen Kaplan; Jonathan Corren; Elliott Levy
Incidence and characteristics of angioedema associated with enalapril.
Archives of internal medicine 2005;165(14):1637-42.
2005: Lien Lai; Thomas B Casale; Jeffrey Stokes
Pediatric allergic rhinitis: treatment.
Immunology and allergy clinics of North America 2005;25(2):283-99, vi.
2005: Stephen T Holgate; R Djukanović; Thomas B Casale; Jean Bousquet
Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2005;35(4):408-16.
2005: Jeffrey Stokes; Richard Kessler; George Philip; Thomas B Casale
Ragweed skin test responsiveness correlates with specific immunoglobulin E levels.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 2005;26(2):103-7.
2005: Stephen Holgate; Thomas B Casale; Sally Wenzel; Jean Bousquet; Yamo Deniz; Colin Reisner
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
The Journal of allergy and clinical immunology 2005;115(3):459-65.
2004: Jaine Brownell; Thomas B Casale
Anti-IgE therapy.
Immunology and allergy clinics of North America 2004;24(4):551-68, v.
2004: Jeffrey Stokes; Thomas B Casale
Rationale for new treatments aimed at IgE immunomodulation.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004;93(3):212-7; quiz 217-9, 271.
2004: Thomas B Casale; Mark S Dykewicz
Clinical implications of the allergic rhinitis-asthma link.
The American journal of the medical sciences 2004;327(3):127-38.
2004: Henry Lin; Kevin M Boesel; Daniel T Griffith; Calman Prussin; Barbara Foster; Francisco A Romero; Robert G Townley; Thomas B Casale
Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
The Journal of allergy and clinical immunology 2004;113(2):297-302.
2003: Calman Prussin; Daniel T Griffith; Kevin M Boesel; Henry Lin; Barbara Foster; Thomas B Casale
Omalizumab treatment downregulates dendritic cell FcepsilonRI expression.
The Journal of allergy and clinical immunology 2003;112(6):1147-54.
2003: Alice B Gottlieb; Thomas B Casale; Ellen Frankel; Bernard S Goffe; Nicholas Lowe; Hans D Ochs; Janet L Roberts; Ken Washenik; Akshay K Vaishnaw; Kenneth B Gordon
CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study.
Journal of the American Academy of Dermatology 2003;49(5):816-25.
2003: Anjuli Nayak; Thomas B Casale; S David Miller; John Condemi; Margaret McAlary; Angel Fowler-Taylor; Giovanni Della Cioppa; Niroo Gupta
Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 2003;24(5):323-9.
2003: Paul Chervinsky; Thomas B Casale; Robert Townley; Ita Tripathy; Simon Hedgecock; Angel Fowler-Taylor; Henry Shen; Howard Fox
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2003;91(2):160-7.
2003: Thomas B Casale; Michael S Blaiss; Erwin Gelfand; Timothy Gilmore; Philip D Harvey; Ian Hindmarch; Estelle Simons; Dennis L Spangler; Stanley J Szefler; Thomas Terndrup; Scott A Waldman; John M Weiler; Dean F Wong
First do no harm: managing antihistamine impairment in patients with allergic rhinitis.
The Journal of allergy and clinical immunology 2003;111(5):S835-42.
2003: Thomas B Casale; Harold S Nelson; James Kemp; Bhash Parasuraman; Thomas Uryniak; Bengt Liljas
Budesonide Turbuhaler delivered once daily improves health-related quality of life and maintains improvements with a stepped-down dose in adults with mild to moderate asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2003;90(3):323-30.
2003: Thomas B Casale
Small airway asthma therapy, challenges, and the future.
Postgraduate medicine 2003;113(2 Suppl):15-20.
2003: Thomas B Casale
Asthma: imaging of the smaller airways.
Postgraduate medicine 2003;113(2 Suppl):13-4.
2003: Thomas B Casale
The pathophysiology of small airway inflammation in asthma.
Postgraduate medicine 2003;113(2 Suppl):7-12.
2003: Thomas B Casale
Small airway inflammation: a new therapeutic target in asthma. Introduction.
Postgraduate medicine 2003;113(2 Suppl):5-6.
2003: Jonathan Corren; Thomas B Casale; Yamo Deniz; Mark Ashby
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.
The Journal of allergy and clinical immunology 2003;111(1):87-90.
2002: Henry Lin; Thomas B Casale
Treatment of allergic asthma.
The American journal of medicine 2002;113 Suppl 9A():8S-16S.
2002: Jonathan Corren; Thomas B Casale
Immunomodulation of asthma: where do we stand?
Current allergy and asthma reports 2002;2(6):433-5.
2002: Harold S Nelson; Wes Stricker; Thomas B Casale; Hershel Raff; Jon A Fourré; David C Aron; Kenneth B Newman
A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids.
Journal of clinical pharmacology 2002;42(3):319-26.
2001: Thomas B Casale; J Condemi; Craig LaForce; Anjuli Nayak; M Rowe; M Watrous; Margaret McAlary; Angel Fowler-Taylor; A Racine; Niroo Gupta; Robert B Fick; Giovanni Della Cioppa
Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;286(23):2956-67.
2001: Thomas B Casale; Harold S Nelson; Wes Stricker; Hershel Raff; K B Newman
Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2001;87(5):379-85.
2001: Thomas B Casale
Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitis.
American journal of respiratory and critical care medicine 2001;164(8 Pt 2):S18-21.
2001: Thomas B Casale
Experience with monoclonal antibodies in allergic mediated disease: seasonal allergic rhinitis.
The Journal of allergy and clinical immunology 2001;108(2 Suppl):S84-8.
2001: Thomas B Casale; B V Amin
Allergic rhinitis/asthma interrelationships.
Clinical reviews in allergy & immunology 2001;21(1):27-49.
2000: J R Stokes; R Hartel; L B Ford; Thomas B Casale
Cannabis (hemp) positive skin tests and respiratory symptoms.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2000;85(3):238-40.
1998: M N Blumenthal; Thomas B Casale; J N Fink; Thomas Uryniak; Frank Casty
Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: a controlled trial.
The Journal of allergy and clinical immunology 1998;101(1 Pt 1):7-13.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.